Neurofibromatosis
Rare Disease·MeSH: Neurofibromatosis 1
Prevalence
30.0 / 100K
7 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 2(3)
Phase 2/Phase 3(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Neurofibromatosis?
BioSniper tracks 7 drugs in development for Neurofibromatosis across 3 companies.
How many clinical trials target Neurofibromatosis?
There are 2 clinical trials targeting Neurofibromatosis tracked by BioSniper.
What is the prevalence of Neurofibromatosis?
The estimated prevalence of Neurofibromatosis is approximately 30.0 per 100,000 population.
Deep-dive into Neurofibromatosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis